Departments of Radiology, Innsbruck Medical University, Innsbruck, Austria.
J Endovasc Ther. 2010 Aug;17(4):492-503. doi: 10.1583/10-3047.1.
To retrospectively evaluate a 12-year experience with endovascular repair of isolated iliac artery aneurysm (IAA).
From August 1997 through July 2009, 91 patients (81 men; mean age 71 years, range 31-90) underwent endovascular treatment for isolated IAA at our department. Of these, 77 patients received stent-grafts either alone or in combination with coils or an Amplatzer vascular plug (n = 2); 1 patient received a Smart stent combined with coils, and 13 patients were treated with coil embolization only. The aneurysms were classified according to location: type I = common iliac artery (CIA), type II = internal iliac artery (IIA), type III = CIA and IIA, and type IV = external iliac artery with/without CIA and/or IIA involvement.
Primary technical success was 90.1% for all aneurysm types and 93.6%, 80%, 88.8%, and 93.3% for types I, II, III, and IV, respectively. Secondary technical success was 96.7% for all types and 97.8%, 95%, 100%, and 93.3%, respectively, for each type. Clinical success was 93.4% for all types and 97.8%, 85%, 100%, and 86.7%, respectively, by type. Complications in 18 (19.8%) patients included 7 type I endoleaks, 3 type II endoleaks, 2 enlarged aneurysm sacs (incomplete embolization), 5 cases of buttock claudication, and 2 stent-graft thromboses. Two patients were converted to open surgery; 10 underwent secondary interventions. Mortality rates were 1.1% (n = 1) at 30 death days and 23.1% (n = 21) over a mean follow-up of 45.9 months (no aneurysm-related death). Cumulative overall survival was 97.7% at 1 year and 47.6% at 10 years. Freedom from aneurysm-related complications was 88.6% at 1 year and 83.5% at 5 years.
Endovascular repair of isolated IAA is a safe and minimally invasive alternative to surgery. However, it may be associated with several complications and must, therefore, be carefully planned.
回顾性评估 12 年来孤立性髂动脉瘤(IAA)的血管内修复治疗经验。
1997 年 8 月至 2009 年 7 月,我院共 91 例(81 例男性;平均年龄 71 岁,范围 31-90 岁)患者接受了孤立性 IAA 的血管内治疗。其中,77 例患者接受了支架移植物治疗,单独使用或联合使用线圈或 Amplatzer 血管塞(n=2);1 例患者接受了 Smart 支架联合线圈治疗,13 例患者仅接受了线圈栓塞治疗。根据位置将动脉瘤分类:I 型=髂总动脉(CIA),II 型=髂内动脉(IIA),III 型=CIA 和 IIA,IV 型=髂外动脉伴/不伴 CIA 和/或 IIA 累及。
所有动脉瘤类型的主要技术成功率为 90.1%,I、II、III 和 IV 型分别为 93.6%、80%、88.8%和 93.3%。所有类型的次要技术成功率为 96.7%,每种类型的成功率分别为 97.8%、95%、100%和 93.3%。所有类型的临床成功率为 93.4%,I 型为 97.8%、85%、100%和 86.7%。18 例(19.8%)患者出现并发症,包括 7 例 I 型内漏、3 例 II 型内漏、2 例动脉瘤囊增大(不完全栓塞)、5 例臀部跛行和 2 例支架移植物血栓形成。2 例患者转为开放手术;10 例患者接受了二次干预。30 天死亡率为 1.1%(n=1),平均随访 45.9 个月后死亡率为 23.1%(n=21)。1 年的总生存率为 97.7%,10 年的生存率为 47.6%。1 年的无动脉瘤相关并发症生存率为 88.6%,5 年的生存率为 83.5%。
孤立性 IAA 的血管内修复是一种安全的微创替代手术方法。然而,它可能与多种并发症相关,因此必须谨慎规划。